GlassScriptPhysician profile
Prathibha N Kumar
NPI 1043268691
$1,524.00
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,181 · 2021: $192 · 2023: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $151.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $205.26 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $180.27 | 2019 | |
| Abbvie INC. | $169.19 | 2019-2023 | |
| Genzyme Corporation | $110.00 | 2019 | |
| Amgen INC. | $104.04 | 2019 | |
| Pfizer INC. | $73.81 | 2019 | |
| Janssen Pharmaceuticals, INC | $72.46 | 2019 | |
| Sanofi-Aventis U.S. LLC | $72.00 | 2021 | |
| Lilly USA, LLC | $70.52 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $68.17 | 2019 | |
| Endo Pharmaceuticals INC. | $56.86 | 2019 | |
| Glaxosmithkline, LLC. | $54.81 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.91 | 2019 | |
| Astellas Pharma US INC | $40.62 | 2019 | |
| Mylan Specialty L.P. | $37.33 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $30.41 | 2019 | |
| Sanofi Pasteur INC. | $29.06 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.13 | 2023 | |
| Lupin INC. | $25.63 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.90 | 2019 | |
| Melinta Therapeutics, LLC | $11.34 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.29 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prathibha Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.